BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 850086)

  • 1. Experimental infections with anaerobic bacteria in mice.
    Wilkins TD; Walker CB; Nitzan D; Salyers AA
    J Infect Dis; 1977 Mar; 135 Suppl():S13-7. PubMed ID: 850086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental anaerobic liver abscess: observations on treatment.
    Lucore CL; McDonald MI; Wharton M; Durack DT
    Liver; 1986 Jun; 6(3):125-32. PubMed ID: 3747743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on bacterial synergism in mice infected with Bacteroides intermedius and Fusobacterium necrophorum.
    Price SB; McCallum RE
    J Basic Microbiol; 1987; 27(7):377-86. PubMed ID: 3449614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between Fusobacterium species and other flora in mixed infection.
    Brook I; Walker RI
    J Med Microbiol; 1986 Mar; 21(2):93-100. PubMed ID: 2936888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen exposures for intrahepatic abscesses produced in mice by nonsporeforming anaerobic bacteria.
    Hill GB
    Antimicrob Agents Chemother; 1976 Feb; 9(2):312-7. PubMed ID: 1267430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary meningitis caused by Bacteroides fragilis and Fusobacterium necrophorum.
    Islam AK; Shneerson JM
    Postgrad Med J; 1980 May; 56(655):351-3. PubMed ID: 7443597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of an experimental Bacteroides fragilis infection in mice.
    Walker CB; Nitzan D; Wilkins TD
    Antimicrob Agents Chemother; 1977 Mar; 11(3):435-40. PubMed ID: 855998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence factors of anaerobic bacteria.
    Bartlett JG
    Johns Hopkins Med J; 1982 Jul; 151(1):1-9. PubMed ID: 7045489
    [No Abstract]   [Full Text] [Related]  

  • 11. Penicillin failure in the treatment of Bacteroides fragilis lung abscess. Experimental study in rabbits.
    Thadepalli H; Kannangara DW; Bach VT
    Chemotherapy; 1983; 29(4):289-93. PubMed ID: 6872619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host response to mixed anaerobic infection with Bacteroides melaninogenicus and Fusobacterium necrophorum.
    McCallum RE; Urbaschek R; Ditter B; Urbaschek B
    Infection; 1983; 11(1):35-40. PubMed ID: 6132881
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647).
    Thadepalli H; Chuah SK; Qazi S; Thadepalli F; Gollapudi SV
    Chemotherapy; 2001; 47(1):43-9. PubMed ID: 11125232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
    Hackman AS; Wilkins TD
    Antimicrob Agents Chemother; 1975 May; 7(5):698-703. PubMed ID: 1041218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects on antibacterial treatment of anaerobic infections.
    Nordbring F; Nord CE
    Scand J Infect Dis Suppl; 1982; 35():59-62. PubMed ID: 6762654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of anaerobic bacteria isolated from the urinary tract. II. Experimental studies.
    Kumazawa J; Kiyohara H; Momose S
    Invest Urol; 1976 Jan; 13(4):309-12. PubMed ID: 1107257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
    Hackman AS; Wilkins TD
    Antimicrob Agents Chemother; 1975 Aug; 8(2):224-5. PubMed ID: 1180547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for infections due to anaerobic bacteria: an overview.
    Finegold SM
    J Infect Dis; 1977 Mar; 135 Suppl():S25-9. PubMed ID: 321708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of metronidazole and clindamycin for the treatment of intra-abdominal anaerobic infection: a multicentre trial.
    Van der Auwera P; Collier J; Goris RJ; Saario I; Willis AT
    J Antimicrob Chemother; 1982 Jul; 10(1):57-66. PubMed ID: 7050070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.